This information was published on 2022-03-29T14:31 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2213100 (IR 1614444) |
| (220) |
12 May 2021
|
| (300) |
US, 17 Nov 2020, 90324805
|
| (511) (510) |
Class 40
Custom manufacturing of pharmaceuticals and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process. Class 42 Research, development, and consulting services in the field of manufacturing processes for pharmaceuticals, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; providing scientific and technical information in the field of pharmaceutical and biomanufacturing. |
| (540) | RESILIENCE |
| (550) | Word |
| (730) |
National Resilience, Inc.
|
| (750) |
Clayton Utz
|
Find out more about publications on the About page.